What does PHARMA OZ do?

PHARMA OZ is a pharmacy in Charleroi. Private Limited, started on 6 January 2023, 1 establishment.

What is the address of PHARMA OZ?

The registered office of PHARMA OZ is located at Rue Trieu Kaisin 121, 6061 Charleroi.

Is PHARMA OZ still active?

Yes. According to the CBE (30 October 2026) PHARMA OZ is active, legal situation “Normale toestand”, started on 6 January 2023.

Is PHARMA OZ registered on Peppol?

Yes, PHARMA OZ is registered on the Peppol network with ID 0208:0795841547.

What is the enterprise number of PHARMA OZ?

The enterprise number of PHARMA OZ is BE0795841547.

When was PHARMA OZ founded?

PHARMA OZ was founded on 6 January 2023.

Who are the directors of PHARMA OZ?

According to the 2025 annual accounts, the directors of PHARMA OZ are: MEHMET OZ.

Is PHARMA OZ a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 6 January 2023; 3 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did PHARMA OZ make in 2025?

PHARMA OZ posted a profit after taxes of € 74,960 in financial year 2025.

What is the revenue of PHARMA OZ?

As a small company, PHARMA OZ is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 136,712.

PHARMA OZ (Private Limited) - Charleroi - BE0795841547

Dossier PHARMA OZ, printed on 30 October 2026 from databakkes.be/en/0795841547/pharma-oz. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 26 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

PHARMA OZ from Charleroi, company number BE0795841547, closed financial year 2025 with a result of € 74,960 after tax. For that financial year PHARMA OZ recorded a gross margin of € 136,712 and equity of € 164,276. Compared with financial year 2024, the result moved from € 75,008 to € 74,960. The company is profitable. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 9, 2026.

What it is worth Growing

€ 164,276

▲ 84% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 74,960

Profit after tax over the fiscal year.

Cash in the bank

€ 269

▼ 98% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 164,176.

Debts at end 2025

Bank debt ≈ 11 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 854,754

▼ 8% vs 2024

€ 78,316 is repaid this year. At this pace the long-term loan is gone in ≈ 11 years.

Owed to suppliers

€ 9,337

▲ 182% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 9,570

▼ 22% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 72,730 Gross margin 2023: € 72,730 First fiscal year in the series	€ 135,428 Gross margin 2024: € 135,428 ▲ 86% vs 2023 (€ 72,730) Favourable step	€ 136,712 Gross margin 2025: € 136,712 ▲ 1% vs 2024 (€ 135,428) Favourable step	▲ 1%
Profit after taxes	€ 14,208 Profit after taxes 2023: € 14,208 First fiscal year in the series	€ 75,008 Profit after taxes 2024: € 75,008 ▲ € 60,801 vs 2023 (€ 14,208) Favourable step	€ 74,960 Profit after taxes 2025: € 74,960 Unchanged (€ 75,008) Unfavourable step
Equity	€ 14,308 Equity 2023: € 14,308 First fiscal year in the series	€ 89,316 Equity 2024: € 89,316 ▲ € 75,008 vs 2023 (€ 14,308) Favourable step	€ 164,276 Equity 2025: € 164,276 ▲ 84% vs 2024 (€ 89,316) Favourable step	▲ 84%
Total debts	€ 1,181,978 Total debts 2023: € 1,181,978 First fiscal year in the series	€ 1,122,302 Total debts 2024: € 1,122,302 ▼ 5% vs 2023 (€ 1,181,978) Favourable step	€ 1,069,790 Total debts 2025: € 1,069,790 ▼ 5% vs 2024 (€ 1,122,302) Favourable step	▼ 5%
Cash	€ 22,931 Cash 2023: € 22,931 First fiscal year in the series	€ 14,767 Cash 2024: € 14,767 ▼ 36% vs 2023 (€ 22,931) Unfavourable step	€ 269 Cash 2025: € 269 ▼ 98% vs 2024 (€ 14,767) Unfavourable step	▼ 98%
Retained profit	€ 14,208 Retained profit 2023: € 14,208 First fiscal year in the series	€ 89,216 Retained profit 2024: € 89,216 ▲ € 75,008 vs 2023 (€ 14,208) Favourable step	€ 164,176 Retained profit 2025: € 164,176 ▲ 84% vs 2024 (€ 89,216) Favourable step	▲ 84%
Bank debt	€ 1,002,980 Bank debt 2023: € 1,002,980 First fiscal year in the series	€ 930,267 Bank debt 2024: € 930,267 ▼ 7% vs 2023 (€ 1,002,980) Favourable step	€ 854,754 Bank debt 2025: € 854,754 ▼ 8% vs 2024 (€ 930,267) Favourable step	▼ 8%
Balance sheet total	€ 1,196,285 Balance sheet total 2023: € 1,196,285 First fiscal year in the series	€ 1,211,617 Balance sheet total 2024: € 1,211,617 ▲ 1% vs 2023 (€ 1,196,285) Unchanged	€ 1,234,065 Balance sheet total 2025: € 1,234,065 ▲ 2% vs 2024 (€ 1,211,617) Unchanged	▲ 2%

Key figures of PHARMA OZ, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMA OZ?

What happened at PHARMA OZ in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 9, 2026 New annual accounts for financial year 2025: profit of € 74,960. Source: NBB ↗
Jan 6, 2023 New establishment in Charleroi. KBO
Jan 6, 2023 Start of the company according to the CBE. KBO

In short

From € 14,208 profit in 2023 to € 74,960 profit in 2025.

Paid € 45,052 in corporate taxes since 2023.

Best year ever: 2024, with € 75,008 profit.

Original PDFs at the National Bank ↗

Management

MEHMET OZ

PHARMA OZ

PHARM-OZ SA 100%

Behind PHARMA OZ is MEHMET OZ. It owns 100% of PHARM-OZ SA itself.

Directors

According to the 2025 annual accounts

MEHMET OZ

Director

Also active at: MAVEPHAR

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Trieu Kaisin 121

6061 Charleroi

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0795.841.547

VAT number

BE 0795.841.547

Registered office

Rue Trieu Kaisin 121, 6061 Charleroi

Names & denominations

PHARMA OZ

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

6 January 2023

Peppol

Active · Active since 29 Apr 2026

Activities · NACE

Detailhandel in farmaceutische producten

Activiteiten van holdings

Holdings

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMA OZ

Warning lights

Financials

What happened to PHARMA OZ?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions